Corporate News     09-Mar-24
Alembic Pharma's oncology formulation facility undergoes USFDA audit
Alembic Pharmaceuticals announced that the United States Food and Drug Administration (US FDA) has conducted an inspection at its Oncology (Injectable and Oral Solid) Formulation Facility (F-2) at Panelav from 28 February 2024 to 8 March 2024. The US FDA issued a Form 483 with four procedural observations.

The Company will provide comprehensive response to USFDA for the observations within the stipulated period.

Previous News
  Alembic Pharma gets USFDA nod for stroke and blood clots drug
 ( Hot Pursuit - 18-Jun-24   14:27 )
  Alembic Pharmaceuticals receives USFDA approval for Dabigatran Etexilate Capsules
 ( Corporate News - 18-Jun-24   18:52 )
  Alembic Pharmaceuticals receives EIR for its oncology unit at Panelav
 ( Corporate News - 06-May-24   08:52 )
  Board of Alembic Pharmaceuticals recommends final dividend
 ( Corporate News - 09-May-24   14:56 )
  Camlin Fine Sciences Ltd leads gainers in 'A' group
 ( Hot Pursuit - 30-Nov-23   12:00 )
  Alembic Pharma records 48% growth in Q3 PAT
 ( Hot Pursuit - 05-Feb-24   16:29 )
  Volumes soar at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 30-Nov-23   14:30 )
  Alembic Pharmaceuticals consolidated net profit declines 85.86% in the March 2022 quarter
 ( Results - Announcements 02-May-22   16:33 )
  Alembic Pharma gets USFDA nod for breast cancer drug
 ( Hot Pursuit - 26-Dec-22   09:44 )
  Alembic Pharmaceuticals consolidated net profit rises 16.78% in the March 2024 quarter
 ( Results - Announcements 09-May-24   15:06 )
  Alembic Pharma gets US FDA nod for heart failure-treatment drug
 ( Hot Pursuit - 30-May-24   14:05 )
Other Stories
  GRP schedules AGM
  01-Jul-24   20:01
  Mahindra & Mahindra domestic PV sales jump 23% in June
  01-Jul-24   20:01
  Vipul Organics constructs new factory in Ambernath, Maharashtra
  01-Jul-24   20:00
  Greaves Engineering launches range of new CPCB IV+ Compliant Gensets
  01-Jul-24   19:41
  Godrej Properties to develop 7-acre land in Thanisandra, North Bengaluru
  01-Jul-24   19:39
  Rama Phosphates AGM scheduled
  01-Jul-24   19:34
  Take Solutions to convene AGM
  01-Jul-24   19:34
  Fischer Medical Ventures partners with Singapore-based Nervotec
  01-Jul-24   19:29
  NIIT appoints Pankaj Jathar as Chief Executive Officer
  01-Jul-24   19:27
  Dynacons Systems recognized as India's Leading Listed ESG Entities 2024
  01-Jul-24   19:26
Back Top